BioCentury
ARTICLE | Company News

EyeGate, RXi Pharmaceuticals deal

October 4, 2010 7:00 AM UTC

RXi partnered with EyeGate to develop RNAi therapeutics by combining RXi's self-delivering rxRNA compounds (sd-rxRNA) with EyeGate's EyeGate II ocular delivery system to treat retinal disorders. sd-rx...